Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Protalix Biotherapeutics
(NY:
PLX
)
1.040
UNCHANGED
Official Closing Price
Updated: 8:00 PM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
67,000
Open
1.030
Bid (Size)
1.030 (177)
Ask (Size)
1.120 (1)
Prev. Close
1.040
Today's Range
1.030 - 1.060
52wk Range
0.9799 - 2.090
Shares Outstanding
73,316,084
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 17, 2024
Via
Benzinga
PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Misses Revenue for Q1 2024
May 10, 2024
PLX stock results show that Protalix BioTherapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
-42.86%
-42.86%
1 Month
-7.14%
-7.14%
3 Month
-5.45%
-5.45%
6 Month
-29.25%
-29.25%
1 Year
-44.97%
-44.97%
More News
Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 10, 2024
Via
Benzinga
Pullix Gains Momentum As Gamestop Exits NFT Space
January 14, 2024
Via
Talk Markets
Protalix BioTherapeutics And 2 Other Penny Stocks Insiders Are Buying
October 23, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Preview: Protalix BioTherapeutics's Earnings
August 04, 2023
Via
Benzinga
Protalix Clocks 40% Decline In Q1 Revenues Reflecting Lower Sales To Brazil
May 04, 2023
Via
Benzinga
Earnings Preview For Protalix BioTherapeutics
February 24, 2023
Via
Benzinga
Earnings Scheduled For March 14, 2024
March 14, 2024
Via
Benzinga
Earnings Preview: Protalix BioTherapeutics
March 13, 2024
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Via
Benzinga
Earnings Preview For Protalix BioTherapeutics
November 03, 2023
Via
Benzinga
Looking Into Protalix BioTherapeutics's Return On Capital Employed
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 07, 2023
Via
Benzinga
Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics
May 10, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 10, 2023
Via
InvestorPlace
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
February 27, 2023
Via
Benzinga
Protalix BioTherapeutics Well Placed to Advance in 2023
December 12, 2022
Via
Talk Markets
Earnings Scheduled For February 27, 2023
February 27, 2023
Via
Benzinga
$12.5 Million Bet On Biodesix? Check Out These 4 Penny Stocks Insiders Are Buying
January 06, 2023
Via
Benzinga
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via
News Direct
Exposures
Product Safety
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via
TheNewswire.com
Exposures
Product Safety
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 29, 2022
Via
Benzinga
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 21, 2022
Via
TheNewswire.com
Earnings Scheduled For November 14, 2022
November 14, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.